Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Other Accumulated Expenses (2018 - 2026)

Updated

Immucell's Other Accumulated Expenses was $21,215 in Q3 2026, down 92.0% from $264,832 a year earlier and down 31.2% from the prior quarter.

Analysis

Immucell (ICCC) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Immucell came in at $22,226, down 90.5% from FY2024.

  • Other Accumulated Expenses shows a five-year compound annual growth rate of -30.5% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $234,552 in FY2024 (+21.7%), $192,754 in FY2023 (+34.0%), $143,872 in FY2022 (-27.7%) and $199,076 in FY2021 (+44.8%).
  • The Q3 2026 figure marks the lowest quarterly Other Accumulated Expenses in data going back to Q4 2018.
  • Compared with a year earlier, Other Accumulated Expenses was higher in two of the last eight quarters, with an average decline of 33.4%.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2024 (growth of 751.7%); the worst was Q3 2026 (a decline of 92.0%).
  • Per Business Quant data, ICCC's Other Accumulated Expenses in the three quarters before Q3 2026 was $30,832 (Q2 2026), $320,147 (Q1 2026) and $22,226 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21,215.00
Jun 30, 2026 30,832.00
Mar 31, 2026 320,147.00
Dec 31, 2025 22,226.00
Sep 30, 2025 264,832.00
Jun 30, 2025 147,790.00
Mar 31, 2025 131,539.00
Dec 31, 2024 234,552.00
Sep 30, 2024 376,112.00
Jun 30, 2024 773,061.00
Mar 31, 2024 328,348.00
Dec 31, 2023 192,754.00
Sep 30, 2023 206,218.00
Jun 30, 2023 90,766.00
Mar 31, 2023 138,040.00
Dec 31, 2022 143,872.00
Sep 30, 2022 262,190.00
Jun 30, 2022 265,728.00
Mar 31, 2022 250,344.00
Dec 31, 2021 199,076.00
API Access

Immucell Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ICCC&period=max&api_key=YOUR_API_KEY